Key result
Increased pericardial fat in metabolic syndrome links to ~10% higher odds of mixed coronary plaques.
Why the study?
The relationship between increased pericardial fat volume and coronary plaque characteristics in patients with metabolic syndrome was unclear.
Is metabolic syndrome associated with increased pericardial fat volume and adverse coronary plaque characteristics in patients with suspected coronary artery disease?
Cross-Sectional (n=811)
No
Is metabolic syndrome associated with increased pericardial fat volume and adverse coronary plaque characteristics in patients with suspected coronary artery disease?
In symptomatic patients with suspected CAD, metabolic syndrome is associated with increased pericardial fat volume, which independently predicts the presence of high-risk mixed and multiple coronary plaques.
Answers are grounded in this paper and cite their sources.
Pericardial fat volume should not yet alter management in metabolic syndrome; leaves open its incremental prognostic value.
The relationship between increased pericardial fat volume (PFV) and coronary plaque characteristics in patients with metabolic syndrome (MetS) is unclear. We aimed to assess PFV and coronary plaque characteristics, including type, stenosis severity, and presence of multiple plaques, among patients with MetS being evaluated for suspected coronary artery disease (CAD). This retrospective study included patients with suspected CAD who underwent computed tomography coronary angiography to exclude the presence of occlusive CAD. MetS diagnosis was based on the American Association of Clinical Endocrinologists criteria. The study included 811 individuals with suspected CAD who underwent MDCT examinations: 127 were in the MetS group, 71 were in the diabetes mellitus (DM) group, and 613 were in the control group (neither DM nor MetS). PFV was higher in the MetS group compared to the DM and the control groups (p=0.003). The MetS group had a higher prevalence of multiple (p<0.001) and mixed coronary plaques (p<0.001) compared to other groups. Increased age [odds ratio (OR) confidence interval (CI)=1.1(1-1.2), p=0.039] and PFV [OR (CI)=1 (1-1.2), p=0.027] showed an independent association with multiple plaque presence, while PFV was an independent predictor of mixed plaque presence [OR (CI)=1.1 (1-1.2), p=0.008]. In conclusion, patients with MetS had larger PFV and a higher prevalence of mixed and multiple coronary plaques than patients without MetS. PFV showed an independent and significant association with mixed and multiple coronary plaques among patients with MetS.
No takes yet. Share an insight, caveat, or question.
Al‐Mosawi et al. (2025) conducted a cross-sectional in Suspected coronary artery disease with metabolic syndrome (n=811). Pericardial fat volume (PFV) was evaluated on Presence of mixed coronary plaques (OR 1.1, 95% CI 1.0-1.2, p=0.008). In patients with metabolic syndrome, increased pericardial fat volume was independently associated with the presence of mixed coronary plaques and multiple coronary plaques.
Synapse has enriched 10 related papers. Consider them for comparative context: